Drug trials in frontotemporal dementia can push forward together

WASHINGTON D.C.: On March 31 and April 1, 95 scientists from 23 companies, 19 academic…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In